ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT RIGNELL MD

Internal Medicine

11,682

$644K

609
575 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

TROY LUNCEFORD MD

Internal Medicine

10,977

$699K

515
441 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $62

SEAN CURZON DO

Internal Medicine

10,975

$838K

429
360 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $62

KEITH LANE MD

Internal Medicine

10,792

$552K

405
379 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

JEROLD HAGEN MD

Internal Medicine

10,699

$688K

623
568 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $62

RICHARD BENNETT MD

Internal Medicine

10,632

$1.01M

632
560 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 23%

$95
Average prescription price

Avg: $62

PHILIP ROBERTS MD

Internal Medicine

10,628

$994K

701
649 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$94
Average prescription price

Avg: $62

RUSSELL MAXWELL M.D.

Internal Medicine

10,616

$708K

491
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $62

RICHARD WHITTINGTON MD

Internal Medicine

10,535

$719K

752
652 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $62

JENNIFER NORRIS M.D.

Internal Medicine

10,310

$674K

529
463 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

JOSHUA ROMNEY MD

Internal Medicine

10,029

$576K

504
415 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $62

J BANE MD

Internal Medicine

10,005

$554K

466
395 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

CORY FERGUSON M.D.

Internal Medicine

9,966

$694K

585
504 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $62

DOUGLAS ROMNEY MD

Internal Medicine

9,910

$706K

643
572 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $62

JOSHUA FRAME DO

Internal Medicine

9,831

$533K

643
583 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

ALEXANDER DEL CASTILLO MD

Internal Medicine

9,689

$366K

591
565 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $62

ROBERT CORNIEA MD

Internal Medicine

9,587

$688K

473
431 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $62

VON WELCH MD

Internal Medicine

9,460

$910K

442
402 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $62

KELTON LUNDSBERG MD

Internal Medicine

9,454

$681K

460
392 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $62

RICHARD OLSEN MD

Internal Medicine

9,447

$572K

444
420 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $62

GLORIA GONZALES M.D.

Internal Medicine

9,438

$455K

499
414 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $62

JUSTIN MANSFIELD M.D.

Internal Medicine

9,407

$614K

614
540 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

DANIEL MADSEN MD

Internal Medicine

9,305

$508K

520
474 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

GORDON SMITH MD

Internal Medicine

9,302

$603K

582
513 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

E GENEBACH MD

Internal Medicine

9,293

$576K

473
459 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank